Assessment and management of intermittent claudication: Importance of secondary prevention

International Journal of Clinical Practice, Supplement

Volumn , Issue 119, 2001, Pages 2-9

  Donnelly, R ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTILIPEMIC AGENT; CILOSTAZOL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIPYRIDAMOLE;

AMPUTATION; ANGIOPLASTY; ATHEROSCLEROSIS; BYPASS SURGERY; CLINICAL FEATURE; DISEASE COURSE; ENDARTERECTOMY; EXERCISE TEST; GANGRENE; INTERMITTENT CLAUDICATION; ISCHEMIC HEART DISEASE; LIMB ISCHEMIA; PATIENT SELECTION; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; ULCER;

ANGIOPLASTY, BALLOON; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTILIPEMIC AGENTS; ARTERIOSCLEROSIS; BLOOD PRESSURE; BLOOD PRESSURE DETERMINATION; DIABETES MELLITUS, TYPE 2; HUMANS; HYPERTENSION; INTERMITTENT CLAUDICATION; PLATELET AGGREGATION INHIBITORS; ULTRASONOGRAPHY;

EID: 0035047002     PISSN: 1368504X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (30)

1. Diagnostic methods for peripheral arterial disease in the San Luis Valley Diabetes Study
2. Edinburgh Artery Study: Prevalence of asymptomatic and symptomatic peripheral arterial disease in the general population
3. The prevalence of peripheral arterial disease in a defined population
4. Update on some epidemiologic features of intermittent claudication: The Framingham study
5. Prevalence of intermittent claudication and its effect on mortality
6. Intermittent claudication: Not so benign
7. Diagnosis and treatment of chronic arterial insufficiency of the lower extremities: A critical review
8. Peripheral vascular disease: Diagnosis and objective evaluation using a mercury strain gauge
9. The ratio of ankle and arm arterial pressure as an independent predictor of mortality
10. Exercise training improves functional status in patients with peripheral arterial disease
11. Noninvasive methods of arterial and venous assessment
12. Exercise rehabilitation programs for the treatment of claudication pain: A meta-analysis
13. The peripheral vascular consequences of smoking
14. Effect of cilostazol on walking distances in patients with intermittent claudication caused by peripheral vascular disease
15. Role of revascularisation in the treatment of claudication
16. Angioplasty for lower limb ischaemia: Time for randomised controlled trials
17. Cochrane Collaborative Review Group on peripheral vascular diseases
18. Factors of prognostic importance for subsequent rest pain in patients with intermittent claudication
19. The role of tobacco cessation, antiplatelet and lipid-lowering therapies in the treatment of peripheral arterial disease
20. The effect of postoperative smoking on femoropopliteal bypass grafts
21. Meta-analysis on efficacy of nicotine replacement therapies in smoking cessation
22. Low-dose aspirin and subsequent peripheral arterial surgery in the Physician's Health Study
23. Aspirin and other anti-platelet drugs: The relationship between dose, effectiveness, and side effects
24. Antithrombotic therapy in peripheral arterial disease
25. A randomised, blinded trial of clopidogrel vs aspirin in patients at risk of ischaemic events
26. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian simvastatin survival (4S) study
27. Cochrane review: Lipid-lowering therapy in the treatment of lower limb atherosclerosis
28. Effect of simvastatin on ischaemic signs and symptoms in the Scandinavian Simvastatin Survival (4S) study
29. Effects of an angiotensin converting enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients
30. Vascular complications of diabetes